Item Type: | Article |
---|---|
Title: | C/EBPβ regulates lipid metabolism and Pparg isoform 2 expression in alveolar macrophages |
Creators Name: | Dörr, D. and Obermayer, B. and Weiner, J.M. and Zimmermann, K. and Anania, C. and Wagner, L.K. and Lyras, E.M. and Sapozhnikova, V. and Lara-Astiaso, D. and Prósper, F. and Lang, R. and Lupiáñez, D.G. and Beule, D. and Höpken, U.E. and Leutz, A. and Mildner, A. |
Abstract: | Pulmonary alveolar proteinosis (PAP) is a syndrome characterized by accumulation of surfactant lipoproteins within the lung alveoli. Alveolar macrophages (AMs) are crucial for surfactant clearance, and their differentiation depends on colony-stimulating factor 2 (CSF2), which regulates the establishment of an AM-characteristic gene regulatory network. Here, we report that the transcription factor CCAAT/enhancer binding protein β (C/EBPβ) is essential for the development of the AM identity, as demonstrated by transcriptome and chromatin accessibility analysis. Furthermore, C/EBPβ-deficient AMs showed severe defects in proliferation, phagocytosis, and lipid metabolism, collectively resulting in a PAP-like syndrome. Mechanistically, the long C/EBPβ protein variants LAP* and LAP together with CSF2 signaling induced the expression of Pparg isoform 2 but not Pparg isoform 1, a molecular regulatory mechanism that was also observed in other CSF2-primed macrophages. These results uncover C/EBPβ as a key regulator of AM cell fate and shed light on the molecular networks controlling lipid metabolism in macrophages. |
Keywords: | Chromatin, Lipid Metabolism, Lipoproteins, Alveolar Macrophages, PPAR gamma, Protein Isoforms, Pulmonary Surfactants, Surface-Active Agents |
Source: | Science Immunology |
ISSN: | 2470-9468 |
Publisher: | American Association for the Advancement of Science |
Volume: | 7 |
Number: | 75 |
Page Range: | eabj0140 |
Date: | September 2022 |
Official Publication: | https://doi.org/10.1126/sciimmunol.abj0140 |
PubMed: | View item in PubMed |
Repository Staff Only: item control page